MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations (Q62476607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

hypertrophic cardiomyopathy

26 February 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Folkert J ten Cate

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Jolanda van der Velden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Joyce Mulders

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Michelle Michels

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Cristobal G Dos Remedios

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Paula A da Costa Martins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Cees B M Oudejans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

29 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

59-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Sudden death in young athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA regulatory networks in cardiovascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Small changes can make a big difference - microRNA regulation of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Role of microRNAs in cardiac remodeling and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Evolution and functions of long noncoding RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Role for miR-204 in human pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Molecular and functional characterization of the melastatin-related cation channel TRPM3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Cardiac myosin binding protein C phosphorylation in cardiac disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

microRNAs in hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA-133 controls cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.09.012

10.1016/J.YJMCC.2013.09.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24083979%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference